Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CLTC | Q00610 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MPO | P05164 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | HEXA | P06865 | 4/20 | 0.43 |
| ▸ | HEXB | P07686 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7709804 | 0.85 | ERCC1 (0.62) | RAD52KMT2AKDM4ETDP1CLTC | |
| SCHEMBL13495341 | 0.84 | ALDH1A1 (0.50) | RAD52KMT2AKDM4ETDP1CLTC | |
| SCHEMBL10040988 | 0.84 | TDP1 (0.60) | KMT2AKDM4ETDP1MEN1CYP1B1 | |
| SCHEMBL13495351 | 0.83 | TDP1 (0.47) | RAD52KMT2AKDM4ETDP1CLTC | |
| SCHEMBL13495362 | 0.82 | BRD1 (0.52) | RAD52KMT2AKDM4ETDP1MEN1 | |
| SCHEMBL24943446 | 0.79 | KDM4E (0.76) | RAD52KMT2AKDM4ECLTCMEN1 | |
| SCHEMBL13496099 | 0.78 | TDP1 (0.46) | RAD52KMT2AKDM4ETDP1CLTC | |
| SCHEMBL13495360 | 0.77 | FTO (0.61) | RAD52KMT2AKDM4ETDP1CLTC | |
| SCHEMBL11435202 | 0.77 | HEXA (0.71) | RAD52KMT2AKDM4EMEN1HEXA | |
| SCHEMBL7709415 | 0.76 | TYMS (0.58) | RAD52KMT2AKDM4EMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329377-B2 | Imide compound and chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | IGF1R, CCNA1, MYC | RAD52 1772/4885KMT2A 219/4885KDM4E 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.